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A YOUNG PATIENT IN KOREA WITH KRUKENBERG 
TUMORS ARISING FROM BREAST CANCER: 
A CASE REPORT
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Metastasis of breast cancer to lung, bone and liver is common, but metastasis to ovaries is rare in Korea. A 31-year-old woman 
diagnosed with breast cancer was referred to our department due to a newly detected adnexal mass via abdomen sonography 
during regular check-up. Imaging studies revealed solid mass on left ovary and enlarged lymph nodes. She underwent a laparotomy 
including hysterectomy, bilateral salpingo-oophorectomy, lymphadenectomy, with a suspected impression of primary ovarian 
neoplasms or Krukenberg tumors. Pathologic fi ndings revealed metastatic adenocarcinoma from breast cancer involving left ovary 
and paraaortic lymph nodes. To our knowledge, this is the youngest Korean patient with Krukenberg tumors from the breast. In Korea, 
since the average age affected by breast cancer is younger than in the West, and the incidence and the mortality of breast cancer has 
increased, possible ovarian metastasis should be kept in mind when Korean patient with breast cancer visits for follow-up.
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Krukenberg tumors, which refer to metastatic ovarian tumors origi-
nating from various sites, account for about 0.7-6.7% of ovarian 
tumors and 10-30% of malignant ovarian tumors [1,2]. The pri-
mary origin sites are usually the gastrointestinal (GI) tract, includ-
ing the stomach and colon, the gall bladder/biliary tract, breast 
and others. In both Asia and the West, most metastatic ovarian 
tumors originate from the GI tract; others origin show different 
proportions because of the incidence and commonly affected ages 
of primary cancer.
Ovarian metastasis from breast cancer is not frequent in Asia and 
breast cancer in Asian women occurs at a younger age between 
30 and 40 with locally-advanced stage III disease, unlike the West 
where women typically present after age 50 with early stage dis-
ease. Here we present the case of the youngest patient in Korea 
with Krukenberg tumors arising from breast cancer. 
Case Report
A 31-year-old married female (gravida 2, para 2) was diagnosed 
with left breast cancer involving axillary lymph nodes metastasis 
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(T3N2M0, stage IIIa) in September 2007. After neoadjuvant che-
motherapy and radiotherapy, she underwent a left modifi ed radi-
cal mastectomy with lymph nodes dissection. The fi nal pathology 
revealed an invasive ductal carcinoma metastasized in 13 of 16 
lymph nodes, and the immunohistochemical results were positive 
for estrogen receptors (ER), progesterone receptors (PR) and hu-
man epidermal growth factor receptor 2 protein (Her2/neu). There 
were no BRCA 1 and BRCA 2 mutations. She was given further 
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chemotherapy with adriamycin and docetaxel, and underwent 
postoperative radiotherapy and hormone therapy. She got a check-
up every six months regularly. In June 2009, after two years under 
the diagnosis of breast cancer, a huge mass with a solid compo-
nent on the left adnexa was found via abdomen ultrasonography. 
The magnetic resonance imaging revealed about 10 cm sized 
solid mass on left ovary and enlarged paraaortic lymph nodes (Fig. 
1). The positron emission tomography–computed tomography 
showed a huge mass with intense fl udeoxyglucose uptake in the 
left adnexa and the paraaortic lymph nodes were enlarged with 
mild uptake (Fig. 2). Plasma cancer-related antigen (CA) 15-3 level 
was gradually elevated (10.3 to 34.4 U/mL among 6 months) and 
CA-125 level was elevated (50.9 U/mL) in June 2009. Esopha-
gogastroduodenoscopy and colonoscopy revealed no significant 
abnormal lesions. After considering all the factors, she underwent 
a laparotomy including total abdominal hysterectomy, bilateral 
salpingo-oophorectomy, total omentectomy, bilateral pelvic lymph 
node dissection and paraaortic lymph node dissection assuming 
primary ovarian cancer or Krukenberg tumors. Pathology, includ-
ing histologic fi ndings, revealed metastatic adenocarcinoma from 
breast cancer involving the left ovary and paraaortic lymph node 
(Fig. 3). Immunohistochemical staining was similar in breast sam-
Fig. 1. The magnetic resonance imaging showed a solid mass lesion 
about 10 cm in size with peripheral cystic portions on left ovary. 
Fig. 2. The positron emission tomography-computed tomography showed 
cystic type, 10 cm in sized, intense fludeoxyglucose uptake on the left 
adnexa and there was mild uptake of paraaortic lymph node metastasis. 
Fig. 3. (A) Breast cancer: invasive ductal carcinoma. (B) Left ovary: metastatic (H&E, ×100).
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ples: positive for ER, PR, Her2/neu and negative c-kit. There were 
no metastatic lesions including in the right ovary, pelvic lymph 
node or other genital organs. She had no postoperative complica-
tions. After 16 days of operation, she received chemotherapy with 
trastuzumab-paclitaxel. No tumor recurrence was shown in the 
abdominal computed tomography that was done as a follow-up 
image in December 2010. 
Discussion
Krukenberg tumors are metastatic ovarian tumors from various 
sites. The primary cancer causing Krukenberg tumors are usually 
GI cancer from either gastric or colorectal cancer, and others are 
breast, gall bladder, pancreas, appendix and unknown. Throughout 
the world, GI cancers are the most common primary cancer. But 
the distribution of affected primary origins differs between the 
Asia and the West. de Waal et al. [3] reported that the GI tract 
was the most common primary site (39%), followed by the breast 
(28%) and gynecologic organs (26%). In other study [4], 76% 
of patients had GI primary cancer, followed by the breast (7%). 
However, in Korea, the primary origin was the stomach (46.2%), 
the colon (38.6%), the appendix (6.3%), and the breast (1.9%) [5]. 
This can be explained by difference in primary cancer incidences. 
In Korea, the incidence of gastric cancer is relatively higher than 
in the west, but that of breast cancer is rather low. Metastasis 
of gastric cancer to the ovaries is therefore common, but that of 
breast cancer is rare in Korea [6]. 
The patients’ age range was 40-50 years [2,4] and almost patients 
were premenopausal in Krukenberg tumors. de Waal et al. [3] 
reported the median age for metastatic ovarian tumors to be 49.5 
(range, 24-79) while the mean age for primary ovarian cancer 
was 55 (range, 11-92). Kiyokawa et al. [4] reported on patients 
ranging in age from 13 to 84 years, with an average age of 45 in 
120 cases. It is known that mean age for Krukenberg tumors is 
10 years younger than that of primary ovarian cancer. But, this is 
explained by the predominance of gastric cancer as a primary sites 
of originating for Krukenberg tumors, which is common in younger 
female [4]. 
In our hospital, between March 2003 and January 2011, one hun-
dred fi fty-eight women were diagnosed Krukengerg tumors with 
pathologically or image studies. The primary sites were stomach 
(72.2%), colon (20.9%), breast (2.5%), appendix (1.3%), hepa-
tobiliary tract (1.3%), pancreas (0.6%), small bowel (0.6%), and 
kidney (0.6%). The median age of all the patients at the time of 
discovery of the metastasis was 45.2 years (range, 21-73 years). 
Even if a small number of patients, our data showed that Kruken-
berg tumors originating breast cancer was rare (2.5%), and primary 
sites of younger patients were almost stomach, as other studies.
Ovarian metastasis from breast cancer are reported at autopsy in 
2.6% to 23.4% in large series, and at oophorectomy for metastat-
ic disease in 25% of patients with breast cancer [7]. Tserkezoglou 
et al. [8], reported the median age of nine patients who had ovar-
ian metastasis from breast cancer to be 54 (rang, 39-73), while 
others have reported a median age of about 46-50 [3,4]. Meta-
static tumors from breast cancer are characterize by the relatively 
small size of the lesion [9]. In pathologic diagnosis, ductal cancer 
is considerably more common in breast cancer, but lobular carcino-
ma spread to the ovary more frequently than ductal carcinoma [6]. 
The route of metastasis to ovary from breast were not identifi ed 
defi nitely, but nodular or infi ltrating involvement were considered. 
Carcinoembryonic antigen and CA 15-3 can be followed over time 
for metastatic breast cancer with CA-125. However, the tests are 
not very sensitive, it can be used with other image studies. 
Ovarian metastasis from breast cancer may appear many years 
after initial diagnosis, because breast cancer is among the more 
slow-growing solid tumors. The median time relapse between 
primary breast cancer diagnosis and diagnosis of ovarian metas-
tasis was fi ve years (range, 0-20 years) in studies by Bigorie et al. 
[10]. Tserkezoglou et al. [8] reported that 56% of patients were 
diagnosed with metastasis to the ovaries five years after breast 
cancer diagnosis. There are no clear guidelines about metastatic 
breast cancer to the ovaries, and it is diffi cult to fi nd until a pa-
tient complains of abdominal pain or distention. Diagnosis and 
cytoreductive surgery have probable survival benefits in recent 
studies [1], and it is important to detect and treat ovarian metas-
tasis promptly. Especially breast cancer in Asian women occurs at 
a younger age and is usually presented and diagnosed at a later 
stage of development, gynecologic evaluation for follow-up after 
breast cancer and screening for distant metastasis should have 
come to the fore in young Asian patients. 
To the best of our knowledge, this is the youngest patient of 
Krukenberg tumors from breast cancer. This report may help im-
prove the current understanding of metastatic ovarian cancer 
originating breast cancer. 
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유방암이 진단된 젊은 한국 여성에서 발견한 크루켄버그종양 1예
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크루켄버그종양은 난소에 전이되는 이차성 난소암으로 전체 난소종양 중 약 0.7-6.7%를 차지하며 주로 40-50대의 여성에서 호발한다. 
원발 부위로는 위, 직장, 유방, 췌담관 등이 있으며 주로 위와 직장에서 전이 된다. 크루켄버그종양은 다른 기관으로의 전이를 의미하기 때
문에 예후가 안 좋다고 알려져 있지만 종양감축술을 시행할 경우 생존율을 올리는데 도움이 되기 때문에 조기 발견은 환자의 삶의 질과 
생존율을 높이는 데 중요하다. 한국과 서양은 원발 부위의 비율에 차이가 있는데 한국은 서양에 비해 유방암에서 전이된 크루켄버그종양
이 드물다. 또한 크루켄버그종양은 난소암에 비해 10년 정도 호발 연령이 어리다. 따라서 유방암을 진단 받은 젊은 한국 여성이 난소에 종
양이 있을 경우 크루켄버그종양일 가능성을 염두해 두고 검사와 추적관찰을 진행하는 것이 전이를 조기 발견하고 생존율을 높이는 데 중
요하다. 본 병원에서는 원발성 유방암 진단 후 난소에 전이된 크루켄버그종양을 진단 받은 31세의 젊은 환자의 증례를 통하여 이를 고찰
해보고자 한다. 
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